We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELEV
126
DELISTED
Elevation Oncology
ELEV
$3.64M 0.05%
+2,396,000
New +$6.32M
ZSQR
127
Z Squared Inc
ZSQR
$271M
$3.61M 0.05%
+116,550
New +$3.63M
CKPT
128
DELISTED
Checkpoint Therapeutics
CKPT
$3.49M 0.05%
+1,413,000
New +$3.86M
HOOK
129
DELISTED
HOOKIPA Pharma
HOOK
$3.39M 0.05%
+385,600
New +$4.28M
ACXP icon
130
Acurx Pharmaceuticals
ACXP
$6.15M
$3.13M 0.05%
59,100
+45,100
+322% +$2.69M
BLTE
131
Belite Bio
BLTE
$6.2B
$3.01M 0.04%
+210,915
New +$4.79M
BGXX
132
DELISTED
Bright Green Corporation Common Stock
BGXX
$2.87M 0.04%
+2,839,422
New +$3.07M
UPH
133
DELISTED
UpHealth, Inc.
UPH
$2.77M 0.04%
1,474,000
-176,000
-11% -$291K
NRXP icon
134
NRX Pharmaceuticals
NRXP
$139M
$2.73M 0.04%
+563,600
New +$3.39M
MLCO icon
135
Melco Resorts & Entertainment
MLCO
$2.17B
$2.63M 0.04%
+215,000
New +$2.66M
BGDE
136
Big Digital Energy Inc
BGDE
$33.1M
$2.61M 0.04%
+69,000
New +$3.82M
ELDN icon
137
Eledon Pharmaceuticals
ELDN
$265M
$2.52M 0.04%
+1,842,803
New +$3.84M
CPRI icon
138
Capri Holdings
CPRI
$1.88B
$2.51M 0.04%
70,000
-61,000
-47% -$2.42M
NTCO
139
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$2.5M 0.04%
+358,767
New +$1.95M
ZIVO
140
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
$2.48M 0.04%
+170,645
New +$2.9M
CELU icon
141
Celularity
CELU
$19.1M
$2.47M 0.04%
+464,300
New +$2.97M
FTCH
142
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$2.42M 0.04%
400,000
+150,000
+60% +$722K
CHWY icon
143
Chewy
CHWY
$9.4B
$2.37M 0.03%
60,000
– –
KA
144
DELISTED
Kineta, Inc. Common Stock
KA
$2.26M 0.03%
+876,000
New +$2.95M
RMTI icon
145
Rockwell Medical
RMTI
$28.5M
$2.1M 0.03%
38,500
+2,100
+6% +$64.6K
RCL icon
146
Royal Caribbean
RCL
$86.7B
$2.08M 0.03%
20,024
-9,976
-33% -$782K
AQST icon
147
Aquestive Therapeutics
AQST
$476M
$1.91M 0.03%
+1,158,000
New +$2.09M
NRSN icon
148
NeuroSense Therapeutics
NRSN
$16.9M
$1.89M 0.03%
+1,266,000
New +$2.22M
CWH icon
149
Camping World
CWH
$694M
$1.81M 0.03%
60,000
+38,143
+175% +$961K
IKT icon
150
Inhibikase Therapeutics
IKT
$347M
$1.79M 0.03%
496,547
+3,054
+0.6% +$11.4K
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.